Preferred Name: Gottfried E. Konecny
Link to Dr. Konecny’s complete CV >
Gottfried E. Konecny is the lead clinician for gynecologic oncology in the Department of Medicine at UCLA. He obtained his medical degree and completed his residency training in obstetrics and gynecology at the University of Munich in Germany. Following his specialist training he focused on clinical breast cancer research and decided to move to the U.S. to pursue postdoctoral studies in the laboratory of Dennis J. Slamon to participate in laboratory and
clinical research that led to the approval of new breast cancer drugs such as trastuzumab and lapatinib. He subsequently undertook research and subspecialty training in gynecologic oncology by completing a gynecologic oncology fellowship at Mayo Clinic in Rochester Minnesota. In 2007 he was recruited back to the University of California as a group leader to the Translational Oncology Research Laboratory of UCLA, to establish a laboratory for preclinical drug and clinical trial development in the area of gynecologic malignancies.
Dr. Konecny's initiatives are primarily directed at using the latest and most effective technologies available to query ovarian, endometrial and cervical cancer tissues, combined with appropriately characterized and molecularly defined
preclinical models to identify new alterations and/or understand the role of known alterations in relevant genes and molecular pathways. As a physician-scientist his work focuses on translating the incredible revolution in our
understanding of the molecular underpinnings of cancer into novel treatment approaches, in which each patient is treated according to the specific genetic alterations of the tumor.